Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
ELAP1Q6UXG2Endosome/lysosome-associated apoptosis and autophagy regulator 1 (Estrogen-induced gene 121 protein)Predicted intracellular proteinsPredicted membrane proteins1Fusion and delivery mediation10.50
ENTKP98073Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain]Disease related genesEnzymesHuman disease related genes1Clinical-translation mediation10.50
EPHA2P29317Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK)1Brain cancerSolid tumour/cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
EPHA3P29320Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1)Cancer-related genesDisease related genesEnzymes1Acute myeloid leukaemiaBrain cancerMalignant haematopoietic neoplasmAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
EQTNQ9NQ60Equatorin (Acrosome formation-associated factor)Predicted membrane proteinsPredicted secreted proteins1Fusion and delivery mediation10.50
EVI2AP22794Protein EVI2A (Ecotropic viral integration site 2A protein homolog) (EVI-2A)Predicted membrane proteins1Other mediation10.50
EVI2BP34910Protein EVI2B (Ecotropic viral integration site 2B protein homolog) (EVI-2B) (CD antigen CD361)CD markersPredicted membrane proteins1Immune mediation10.50
FCG2AP12318Low affinity immunoglobulin gamma Fc region receptor II-a (IgG Fc receptor II-a) (CDw32) (Fc-gamma RII-a) (Fc-gamma-RIIa) (FcRII-a) (CD antigen CD32)CD markersFDA approved drug targetsHuman disease related genes1Chronic kidney diseaseLupus erythematosusThrombocytopeniaClinical-translation mediationFusion and delivery mediationImmune mediation10.50
FLRT3Q9NZU0Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin-like domain-containing leucine-rich transmembrane protein 3)Disease related genesHuman disease related genesPotential drug targets1Adhesion and uptake mediationReceptor-signaling mediation10.50
FR1L5A0AVI2Fer-1-like protein 51Fusion and delivery mediation10.50
FR1L6Q2WGJ9Fer-1-like protein 6Plasma proteinsPredicted membrane proteins1Other mediation10.50
FUT2Q10981Galactoside alpha-(1,2)-fucosyltransferase 2 (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2) (SE2) (Secretor blood group alpha-2-fucosyltransferase) (Secretor factor) (Se) (Type 1 galactoside alpha-(1,2)-fucosyltransferase FUT2) (EC 2.4.1.69) (Type 2 galactoside alpha-(1,2)-fucosyltransferase FUT2) (EC 2.4.1.344)Blood group antigen proteinsEnzymesMetabolic proteins1Metabolism mediationReceptor-signaling mediation10.50
GALR1P47211Galanin receptor type 1 (GAL1-R) (GALR-1)7Fusion and delivery mediationReceptor-signaling mediation10.50
GAPTQ8N292Protein GAPT (GRB2-binding adapter protein, transmembrane) (Growth factor receptor-bound protein 2-binding adapter protein, transmembrane)Predicted intracellular proteins1Immune mediation10.50
GBRA1P14867Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) (GABAAR subunit alpha-1)Disease related genesFDA approved drug targetsHuman disease related genes4Acute respiratory distress syndromeAnxiety disorderChronic insomniaClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
GBRA2P47869Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) (GABAAR subunit alpha-2)4General pain disorderIndeterminate colitisIntentional self-harmClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
GBRA3P34903Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) (GABAAR subunit alpha-3)FDA approved drug targetsPredicted membrane proteinsTransporters4Anxiety disorderIndeterminate colitisIntentional self-harmClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
GBRA5P31644Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) (GABAAR subunit alpha-5)4Adaptive immunity immunodeficiencyAlzheimer diseaseAutism spectrum disorderClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
GBRG1Q8N1C3Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) (GABAAR subunit gamma-1)FDA approved drug targetsPredicted membrane proteins4Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
GBRG3Q99928Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) (GABAAR subunit gamma-3)FDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins4Alzheimer diseaseAnxiety disorderCorneal diseaseClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
GGTA1Q4G0N0Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase (Glycoprotein alpha-galactosyltransferase 1 pseudogene)Predicted intracellular proteins1Other mediation10.50
GHRP10912Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)]Disease related genesFDA approved drug targetsHuman disease related genes1COVID-19MalariaMiddle East Respiratory SyndromeAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
GINM1Q9NU53Glycoprotein integral membrane protein 1Predicted intracellular proteinsPredicted membrane proteins1Other mediation10.50
GLP1RP43220Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R)7Acute diabete complicationAlzheimer diseaseCardiovascular diseaseClinical-translation mediationFusion and delivery mediationMetabolism mediation10.50
GLP2RO95838Glucagon-like peptide 2 receptor (GLP-2 receptor) (GLP-2-R) (GLP-2R)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Bowel habit changeDigestive system diseaseIndeterminate colitisClinical-translation mediationReceptor-signaling mediation10.50

426-450 of 1,200 proteins

Page